Evidence map›Paper›PMID 19281331›Full record

GuidelineClinical infectious diseases : an official publication of the Infectious Diseases Society of America2009

Seasonal influenza in adults and children--diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America.

Scott A Harper, John S Bradley, Janet A Englund, Thomas M File, Stefan Gravenstein, Frederick G Hayden, Allison J McGeer, Kathleen M Neuzil, Andrew T Pavia, Michael L Tapper and 3 more

Registry-linked trialAbstract readPractice Guideline
In one paragraph

Guideline in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05170009 (Randomized Double-blind, Placebo-controlled Single Center Pilot Study to Evaluate the Efficacy and Safety of Baloxavir in Combination With Oseltamivir in Adult Allogeneic Bone Marrow Transplant Recipients With Influenza), which is not on this map. Cited by 268 papers, 9 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
268citing papers in PubMed, 9 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05170009 phase2 / phase3terminatednot on this mapstarted 2022, after this paper: background citation

Randomized Double-blind, Placebo-controlled Single Center Pilot Study to Evaluate the Efficacy and Safety of Baloxavir in Combination With Oseltamivir in Adult Allogeneic Bone Marrow Transplant Recipients With Influenza

TypeinterventionalSponsorWeill Medical College of Cornell UniversityRan2022 to 2024Enrolled2ConditionsInfluenzaArmsBaloxavir Marboxil, Placebo, Oseltamivir
3 · Its place in the literature

Who cites it

268 citing papers in PubMed, 9 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Guideline
  4. Guideline
  5. Pooled it
  6. Pooled it
  7. Guideline
  8. Pooled it
  9. Pooled it
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Trial
  16. Long-acting Neuraminidase Inhibitor Laninamivir Octanoate as Post-exposure Prophylaxis for Influenza.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2016
    Trial
  17. Trial
  18. Trial
  19. Laninamivir octanoate for post-exposure prophylaxis of influenza in household contacts: a randomized double blind placebo controlled trial.Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy · 2013
    Trial
  20. Trial

208 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Scott A HarperCenters for Disease Control and Prevention, Atlanta, Georgia, USA. svh9@cdc.gov
John S Bradley
Janet A Englund
Thomas M File
Stefan Gravenstein
Frederick G Hayden
Allison J McGeer
Kathleen M Neuzil
Andrew T Pavia
Michael L Tapper
Timothy M Uyeki
Richard K Zimmerman
Expert Panel of the Infectious Diseases Society of America

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Guidelines for the treatment of persons with influenza virus infection were prepared by an Expert Panel of the Infectious Diseases Society of America. The evidence-based guidelines encompass diagnostic issues, treatment and chemoprophylaxis with antiviral medications, and issues related to institutional outbreak management for seasonal (interpandemic) influenza. They are intended for use by physicians in all medical specialties with direct patient care, because influenza virus infection is common in communities during influenza season and may be encountered by practitioners caring for a wide variety of patients.

Indexed as

Disease OutbreaksInfluenza, HumanAdultAntiviral AgentsChemopreventionChildDisease ManagementGuideline AdherenceHumansRisk FactorsSeasonsAntiviral Agents

Identifiers

PMID19281331
PMCPMC7107965

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.